a good suggestion Privacy Policy Update History Click here to view the current Privacy Policy. July 3rd, 2017: Revised TRUSTe statement, added more specific information in regard to third party service providers and updated statements on tracking technologies and disclosure of personal data. More specifically, we may share your information with third parties who provide services on our behalf. They are authorized to use the information only as necessary to provide these services to us. We may also disclose your information in response to lawful requests. June 26th, 2017: Additional clarity on user created profiles. Specifically that usernames become publicly visible on the Drugs.com web site upon registration. September 12th, 2016: Additional clarity on user created profiles. Specifically that ANY profile you create will be publicly accessible unless otherwise stated. July 25th, 2016: Additional clarity on third party service providers. Specifically that we do NOT share personal information with these entities. Removed reference to Flash LSOs, which are no longer utilized. November 9th, 2015: Added clarity on third party service providers and what information we share with these entities. Added link to specific Mobile Application Privacy Policy. August 13th, 2015: Our employees do not directly access or share personally identifiable information with any third party. A clause was removed in relation to this. A clause was added stating we will respond to support requests within a reasonable timeframe. April 8th, 2015: A clause was added, stating that personally identifiable information will be de-identified, analyzed and compared at an aggregate level for statistical purposes. More detail included regarding Flash LSOs (Local shared objects). Added more information about public profiles. Privacy Policy updates have been logged since Apr 8th, 2015 to make it easier to follow changes over time. No updates were logged prior to this date. FDA Consumer Updates Depression: FDA-Approved Medications May Help Dealing with ADHD: What You Need to Know Making Decisions for Your Health: Getting the Info You Need FDA: Cutting-Edge Technology Sheds Light on Antibiotic Resistance More FDA updates Recently Approved Lonhala Magnair Lonhala Magnair (glycopyrrolate) is a long-acting muscarinic antagonist (LAMA) bronchodilator for... Ozempic Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) analog administered once-weekly for the... Ogivri Ogivri (trastuzumab-dkst) is a HER2 / neu receptor antagonist biosimilar to Herceptin indicated for... Sublocade Sublocade (buprenorphine) is a once-monthly injectable partial opioid agonist formulation for the... More considered necessary
due to Privacy Policy Update History typical
EmoticonEmoticon